Mohammad Mahboubi-Rabbani

Affiliations

Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Publications (12)

Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase.

Archiv der Pharmazie

Avec: Iman Mahlooji , Maryam Shokri , Rana Manoochehri , Mohammad Mahboubi-Rabbani , Elham Rezaee , Sayyed Abbas Tabatabai

STAT3-mediated Apoptotic-enhancing Function of Sclareol Against Breast Cancer Cells and Cell Sensitization to Cyclophosphamide.

Iranian journal of pharmaceutical research : IJPR

Avec: Havva Afshari , Mitra Nourbakhsh , Niloufar Salehi , Mohammad Mahboubi-Rabbani , Afshin Zarghi , Shokoofe Noori

Lipoxygenase Inhibitors as Cancer Chemopreventives: Discovery, Recent Developments and Future Perspectives.

Current medicinal chemistry

Avec: Mohammad Mahboubi-Rabbani , Afshin Zarghi

HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies.

Iranian journal of pharmaceutical research : IJPR

Avec: Mohammad Mahboubi-Rabbani , Maryam Abbasi , Zahra Hajimahdi , Afshin Zarghi

Novel Benzo[4,5]imidazo[1,2-

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

Avec: Maryam Bayanati , Mona Khoramjouy , Mehrdad Faizi , Mahsa Azami Movahed , Mohammad Mahboubi-Rabbani , Afshin Zarghi

Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer.

European journal of medicinal chemistry

Avec: Ali Aliabadi , Elham Khanniri , Mohammad Mahboubi-Rabbani , Maryam Bayanati

Chalcones as Potential Cyclooxygenase-2 Inhibitors: A Review.

Anti-cancer agents in medicinal chemistry

Avec: Mohammad Mahboubi-Rabbani , Rosa Zarei , Mehdi Baradaran , Maryam Bayanati , Afshin Zarghi

Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023).

Expert opinion on therapeutic patents

Avec: Mohammad Mahboubi-Rabbani , Amir Hossein Abdolghaffari , Mahsa Ghesmati , Ali Amini , Afshin Zarghi

Dual Human Carbonic Anhydrase/Cyclooxygenase-2 Inhibitors: A Promising Approach for Cancer Treatment.

Anti-cancer agents in medicinal chemistry

Avec: Mohammad Mahboubi-Rabbani , Afshin Zarghi

Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their Structural Diversity and Mechanism of Action.

Anti-cancer agents in medicinal chemistry

Avec: Mohammad Mahboubi-Rabbani , Maryam Abbasi , Afshin Zarghi

Design, Synthesis, Docking Studies, and Biological Evaluation of Novel 2- Hydroxyacetophenone Derivatives as Anti-HIV-1 Agents.

Current HIV research

Avec: Samira Sooreni Oliaie , Mahdieh Safakish , Rouhollah Vahabpour Roudsari , Mohammad Mahboubi-Rabbani , Zahra Hajimahdi , Afshin Zarghi

Prediction of dual NF-κB/IκB inhibitors using an integrative

Journal of biomolecular structure & dynamics

Avec: Maryam Abbasi , Mohammad Mahboubi-Rabbani , Khosrow Kashfi , Hojjat Sadeghi-Aliabadi

Réseau de co-auteurs

Afshin Zarghi 9 collaborations

Maryam Abbasi 3 collaborations

Maryam Bayanati 3 collaborations

Zahra Hajimahdi 2 collaborations

Iman Mahlooji 1 collaboration

Maryam Shokri 1 collaboration

Rana Manoochehri 1 collaboration

Elham Rezaee 1 collaboration

Sayyed Abbas Tabatabai 1 collaboration

Havva Afshari 1 collaboration

Mitra Nourbakhsh 1 collaboration

Niloufar Salehi 1 collaboration

Shokoofe Noori 1 collaboration

Mona Khoramjouy 1 collaboration

Mehrdad Faizi 1 collaboration

Mahsa Azami Movahed 1 collaboration

Ali Aliabadi 1 collaboration

Elham Khanniri 1 collaboration

Rosa Zarei 1 collaboration

Mehdi Baradaran 1 collaboration

Amir Hossein Abdolghaffari 1 collaboration

Mahsa Ghesmati 1 collaboration

Ali Amini 1 collaboration

Samira Sooreni Oliaie 1 collaboration

Mahdieh Safakish 1 collaboration

Rouhollah Vahabpour Roudsari 1 collaboration

Khosrow Kashfi 1 collaboration

Hojjat Sadeghi-Aliabadi 1 collaboration